Olympiad Research’s iShares Biotechnology ETF IBB Stock Holding History

Olympiad Research’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$294K	Buy	+2,514	New	+$312K	0.16%	148
2022 Q2	–	Sell	-6,031	Closed	-$786K	–	315
2022 Q1	$786K	Sell	6,031 -3,376	-36%	-$440K	0.24%	106
2021 Q4	$1.44M	Sell	9,407 -1,548	-14%	-$240K	0.52%	61
2021 Q3	$1.77M	Buy	10,955 +1,880	+21%	+$316K	0.54%	72
2021 Q2	$1.49M	Sell	9,075 -9,587	-51%	-$1.48M	0.52%	78
2021 Q1	$2.81M	Sell	18,662 -1,748	-9%	-$278K	1.2%	27
2020 Q4	$3.09M	Buy	20,410 +12,128	+146%	+$1.73M	1.78%	14
2020 Q3	$1.12M	Sell	8,282 -36,182	-81%	-$4.91M	0.57%	25
2020 Q2	$6.08M	Buy	+44,464	New	+$5.67M	4.31%	1
2020 Q1	–	Sell	-2,268	Closed	-$273K	–	312
2019 Q4	$273K	Buy	+2,268	New	+$253K	0.21%	112

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Olympiad Research's IBB Position: Q3 2022 in Review

Olympiad Research opened a new position in iShares Biotechnology ETF (IBB) in Q3 2022: 2,514 shares worth $294K. The stake represents 0.16% of the portfolio and ranks #148 among its holdings. This is a return to the name: Olympiad Research previously reported a position in IBB as recently as Q1 2022.

Olympiad Research first reported a position in IBB in Q4 2019 and has held it in 10 quarters since. The position peaked at $6.08M in Q2 2020. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Olympiad Research held 2,514 shares of iShares Biotechnology ETF worth $294K as of Q3 2022.
iShares Biotechnology ETF was a new Olympiad Research position in Q3 2022.
iShares Biotechnology ETF made up 0.16% of Olympiad Research's portfolio in Q3 2022, its #148 holding.
Olympiad Research first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 10 quarters since.
Olympiad Research's iShares Biotechnology ETF position peaked at $6.08M in Q2 2020.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.